Nynex Overview
- Status
-
Private
- Employees
-
68,100
Nynex General Information
Description
Developer of small molecule deubiquitinase inhibitors (DUBs) intended to boost cancer treatment. The company is currently operating in Stealth mode.
Contact Information
Corporate Office
- 1095 Avenue Of Americas
- New York, NY 10036
- United States
Corporate Office
- 1095 Avenue Of Americas
- New York, NY 10036
- United States
Nynex Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nynex Investments & Acquisitions (2)
Nynex’s most recent deal was a Merger/Acquisition with Horizon Cellular Telephone Company for . The deal was made on 09-Oct-1996.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Horizon Cellular Telephone Company | 09-Oct-1996 | Merger/Acquisition | Telecommunications Service Providers | ||
| PhoneWatch | 01-Jan-1991 | Joint Venture | Security Services (B2B) |
Nynex FAQs
-
Where is Nynex headquartered?
Nynex is headquartered in New York, NY.
-
What is the size of Nynex?
Nynex has 68,100 total employees.
-
What industry is Nynex in?
Nynex’s primary industry is Biotechnology.
-
Is Nynex a private or public company?
Nynex is a Private company.
-
What is Nynex’s current revenue?
The current revenue for Nynex is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
